Drug · DIN 02330326
POLYLAX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 16, 2016; first marketed July 26, 2010.
- Drug Identification Number (DIN)
- 02330326
- Company (DIN owner)
- Seaford Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Powder For Solution
- Route
- Oral
- Therapeutic class (ATC)
- Macrogol A06AD15
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| POLYETHYLENE GLYCOL 3350 | 100 % |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “polylax”. A notice may cover another product or only some lots: read it to see what it covers.
- PolyLax (2013-10-16)January 13, 2014 · Drugs · Product safety · Type III